Filtered By:
Infectious Disease: Coronavirus
Management: Partnerships

This page shows you your search results in order of date.

Order by Relevance | Date

Total 23 results found since Jan 2013.

Why the U.S. Doesn ’t Have a Nasal Vaccine for COVID-19
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works at the places where the virus gets into the body, will likely prove useful. Here, though, the U.S. is losing its edge. In September, India approved a nasal COVID-19 vacc...
Source: TIME: Health - October 31, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

New head of U.S. aid program for HIV/AIDS vows to refocus attention on the other, ‘silent’ pandemic
On 13 June, John Nkengasong, 58, was appointed the first African-born head of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a program that helps more than 50 countries respond to their HIV/AIDS epidemics. Nkengasong, who grew up in Cameroon and became a U.S. citizen in 2007, previously ran the Africa Centres for Disease Control and Prevention (Africa CDC). PEPFAR is credited with helping save more than 20 million lives since its inception in 2003. It had a $10.7 billion budget in 2021, more than half of it spent on HIV treatment and care. The agency has relied on an acting director since Deborah Birx...
Source: Science of Aging Knowledge Environment - July 5, 2022 Category: Geriatrics Source Type: research

UArizona Health Sciences Researchers to Study Long COVID as Part of National Collaborative
This study of post-acute sequelae of SARS-CoV-2, which is aimed at understanding the reasons for persistence of symptoms and organ involvement, assumes tremendous importance for us to devise new treatments and cures to address the long-term consequences of this pandemic, " said Dr.Sairam Parthasarathy, one of the project ' s multiple principal investigators.In addition to Parthasarathy, who is a professor of medicine and chief of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine at the UArizona College of Medicine – Tucson and a BIO5 Institute member, principal investigators include Dr.Marilyn Glassber...
Source: The University of Arizona: Health - December 16, 2021 Category: Universities & Medical Training Authors: mittank Source Type: research

What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
You don’t want to be a virus in Dr. David Ho’s lab. Pretty much every day since the COVID-19 pandemic began, Ho and his team have done nothing but find ways to stress SARS-CoV-2, the virus that causes the disease. His goal: pressure the virus relentlessly enough that it mutates to survive, so drug developers can understand how the virus might respond to new treatments. As a virologist with decades of experience learning about another obstinate virus, HIV, Ho knows just how to apply that mutation-generating stress, whether by starving the virus, bathing it in antibodies that disrupt its ability to infect cells, ...
Source: TIME: Health - June 11, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Genetics Magazine Source Type: news

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH initiative—called UNIT...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

The COVID-19 Virus Is Mutating. What Does That Mean for Vaccines?
As we enter the second year of living with the new coronavirus SARS-CoV-2, the virus is celebrating its invasion of the world’s population with yet more mutated forms that help it to spread more easily from person to person. One, first detected in the U.K. in December, has already raised alarms about whether the COVID-19 virus is now escaping from the protection that vaccines just being rolled out now might provide. The variant has also been found in the U.S. Already, U.K. officials have tightened lockdowns in England, Scotland and Wales, and over the holidays, more than 40 countries banned travelers from the region ...
Source: TIME: Health - January 7, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Child COVID Cases Have Increased 28% Over The Last Two Weeks, American Academy Of Pediatrics Says
(CNN) — As officials continue to warn about traveling over the holidays amid the fall surge, health experts are also investigating the virus’ impact on children. There were more than 144,000 new cases of Covid-19 reported among children last week, the American Academy of Pediatrics (AAP) said Monday. Over the last two weeks, there has been a 28% increase in child Covid-19 cases and children now account for more than 11% of all confirmed coronavirus cases in the US, according to the AAP. About 144,145 new cases among children 17 and under were reported from November 12 to 19, AAP said. As of Monday, the US has r...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 24, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Covid-19 Boston, MA Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Coronavirus Source Type: news

COVID-19 Vaccines Are Coming. Here ’s What to Expect
Vaccines normally take decades to develop and test, but two COVID-19 shots, from Moderna and Pfizer (in partnership with BioNTech), have gone from nonexistent to about 95% effectiveness in 10 months. Public-health officials and governments now have the dual challenge of convincing the public that the vaccines are both safe and scientifically sound, as well as figuring out how to distribute billions of doses. Here’s what we know so far about how that’s going. When can I get vaccinated? That depends. Manufacturers have already begun producing vaccines, betting that they will be effective, so they can be ready to ...
Source: TIME: Science - November 19, 2020 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

The Covid Pandemic: Broadening the Discourse
Thailand’s COVID-19 response an example of resilience and solidarity: a UN Resident Coordinator’s BlogBy Asoka BandarageCOLOMBO, Sri Lanka, Nov 10 2020 (IPS) SARS-CoV-2, the corona virus that causes COVID-19, has been spreading exponentially across the world over the last ten or so months. As of November 6th, according to the Center for Systems Science at Johns Hopkins University, there have been 49,195,581 cases of COVID-19, including 1,241,031 deaths. More than a third of the global population has been placed on lockdown. The global economy is experiencing the deepest global recession since World War 2 and massive n...
Source: IPS Inter Press Service - Health - November 10, 2020 Category: International Medicine & Public Health Authors: Asoka Bandarage Tags: Featured Global Headlines Health Human Rights Humanitarian Emergencies Peace TerraViva United Nations Source Type: news

Physician-Scientist Leads Program to Tackle COVID-19 Health Disparities in Arizona
Brittany Uhlorn Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities. Monday BIO5 Institute201407064__DSC0561-web.JPG Dr. Sairam Parthasarathy, professor of medicine and chief of the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine in the UArizona College of Medicine – Tucson, was recently named one of 11 lead investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.HealthBIO5College of Medicine - TucsonCOVID-19 Media contact(s)Brittany Uhlo...
Source: The University of Arizona: Health - October 30, 2020 Category: Universities & Medical Training Authors: mittank Source Type: research